Literature DB >> 17822674

A unique and highly efficient non-viral DNA/siRNA delivery system based on PEI-bisepoxide nanoparticles.

Archana Swami1, Raj K Kurupati, Atul Pathak, Y Singh, P Kumar, K C Gupta.   

Abstract

Delivery of DNA and siRNA into mammalian cells is a powerful technique in treating various diseases caused by single gene defects. Herein, we report a highly efficient delivery system using 1,4-butanediol diglycidyl ether (bisepoxide) crosslinked polyethylenimine (PEI) nanoparticles (PN). The nanoparticle/DNA complexes (nanoplexes) exibited approximately 2.5- to 5.0-fold gene transfer efficacy and decreased cytotoxicity in cultured cell lines, compared to the native PEI (25 kDa) (gold standard) and commercially available transfection agents such as Lipofectamine 2000 and Fugene. The bisepoxide crosslinking results in change in amine ratio in PEI; however, it retains the net charge on PN unaltered. A series of nanoparticles obtained by varying the degree of crosslinking was found to be in the size range of 69-77 nm and the zeta potential varying from +35 to 40 mV. The proposed system was also found to deliver siRNA efficiently into HEK cells, resulting in approximately 70% suppression of the targetted gene (GFP).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17822674     DOI: 10.1016/j.bbrc.2007.08.073

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  A novel polymer-lipid hybrid nanoparticle for efficient nonviral gene delivery.

Authors:  Jian Li; Ying-zi He; Wen Li; Yun-zhen Shen; Yu-ru Li; Yun-feng Wang
Journal:  Acta Pharmacol Sin       Date:  2010-03-29       Impact factor: 6.150

2.  Synthesis and characterization of mannosylated pegylated polyethylenimine as a carrier for siRNA.

Authors:  Najung Kim; Dahai Jiang; Ashley M Jacobi; Kim A Lennox; Scott D Rose; Mark A Behlke; Aliasger K Salem
Journal:  Int J Pharm       Date:  2011-08-12       Impact factor: 5.875

Review 3.  Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine.

Authors:  Hui Yi Xue; Shimeng Liu; Ho Lun Wong
Journal:  Nanomedicine (Lond)       Date:  2014-02       Impact factor: 5.307

4.  Delivery of microRNA-146a with polyethylenimine nanoparticles inhibits renal fibrosis in vivo.

Authors:  Yoshiyuki Morishita; Toshimi Imai; Hiromichi Yoshizawa; Minami Watanabe; Kenichi Ishibashi; Shigeaki Muto; Daisuke Nagata
Journal:  Int J Nanomedicine       Date:  2015-05-11

Review 5.  Nano-sized carriers in gene therapy for renal fibrosis in vivo.

Authors:  Haruhisa Miyazawa; Keiji Hirai; Susumu Ookawara; Kenichi Ishibashi; Yoshiyuki Morishita
Journal:  Nano Rev Exp       Date:  2017-06-13

6.  Nanoparticles to Knockdown Osteoporosis-Related Gene and Promote Osteogenic Marker Expression for Osteoporosis Treatment.

Authors:  Patricia Mora-Raimundo; Daniel Lozano; Miguel Manzano; María Vallet-Regí
Journal:  ACS Nano       Date:  2019-05-13       Impact factor: 15.881

7.  FGF receptor-mediated gene delivery using ligands coupled to PEI-β-CyD.

Authors:  Yiping Hu; Guping Tang; Jun Liu; Wenxiang Cheng; Ye Yue; Jinchao Li; Peng Zhang
Journal:  J Biomed Biotechnol       Date:  2012-04-11

8.  Ultra-high throughput synthesis of nanoparticles with homogeneous size distribution using a coaxial turbulent jet mixer.

Authors:  Jong-Min Lim; Archana Swami; Laura M Gilson; Sunandini Chopra; Sungyoung Choi; Jun Wu; Robert Langer; Rohit Karnik; Omid C Farokhzad
Journal:  ACS Nano       Date:  2014-05-28       Impact factor: 15.881

9.  Osteoporosis Remission and New Bone Formation with Mesoporous Silica Nanoparticles.

Authors:  Patricia Mora-Raimundo; Daniel Lozano; Manuel Benito; Francisca Mulero; Miguel Manzano; María Vallet-Regí
Journal:  Adv Sci (Weinh)       Date:  2021-06-06       Impact factor: 16.806

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.